Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/med.20179 http://scihub22266oqcxt.onion/10.1002/med.20179 19844936!7168424!19844936     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Med+Res+Rev 2011 ; 31 (1): 118-60 Nephropedia Template TP {{tp|p=19844936|t=2011. The next ten stories on antiviral drug discovery (part E): advents, advances, and adventures |pdf=|usr=}}{{19844936}} gab.com Text The next ten stories on antiviral drug discovery (part E): advents, advances, and adventures JO: Med Res Rev http://www.kidney.de/pget.php?&tw=1&pmid=19844936 #FOAvip This review article presents the fifth part (part E) in the series of stories on antiviral drug discovery. The ten stories belonging to this fifth part are dealing with (i) aurintricarboxylic acid; (ii) alkenyldiarylmethanes; (iii) human immunodeficiency virus (HIV) integrase inhibitors; (iv) lens epithelium-derived growth factor as a potential target for HIV proviral DNA integration; (v) the status presens of neuraminidase inhibitors NAIs in the control of influenza virus infections; (vi) the status presens on respiratory syncytial virus inhibitors; (vii) tricyclic (1,N-2-ethenoguanine)-based acyclovir and ganciclovir derivatives; (viii) glycopeptide antibiotics as antivirals targeted at viral entry; (ix) the potential (off-label) use of cidofovir in the treatment of polyoma (JC and BK) virus infections; and (x) finally, thymidine phosphorylase as a target for both antiviral and anticancer agents. Twit Text FOAVip The next ten stories on antiviral drug discovery (part E): advents, advances, and adventures ????Med Res Rev http://www.kidney.de/pget.php?&tw=1&pmid=19844936 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=19844936 #FOAvip English Wikipedia <ref>{{Cite pmid|19844936}}</ref> The next ten stories on antiviral drug discovery (part E): advents, advances, and adventures #MMPMID19844936 De Clercq E Med Res Rev 2011[Jan]; 31 (1): 118-60 PMID19844936show ga This review article presents the fifth part (part E) in the series of stories on antiviral drug discovery. The ten stories belonging to this fifth part are dealing with (i) aurintricarboxylic acid; (ii) alkenyldiarylmethanes; (iii) human immunodeficiency virus (HIV) integrase inhibitors; (iv) lens epithelium-derived growth factor as a potential target for HIV proviral DNA integration; (v) the status presens of neuraminidase inhibitors NAIs in the control of influenza virus infections; (vi) the status presens on respiratory syncytial virus inhibitors; (vii) tricyclic (1,N-2-ethenoguanine)-based acyclovir and ganciclovir derivatives; (viii) glycopeptide antibiotics as antivirals targeted at viral entry; (ix) the potential (off-label) use of cidofovir in the treatment of polyoma (JC and BK) virus infections; and (x) finally, thymidine phosphorylase as a target for both antiviral and anticancer agents. |Acyclovir/therapeutic use[MESH] |Antiviral Agents/*pharmacology/therapeutic use[MESH] |DNA, Viral/metabolism[MESH] |Drug Discovery/*trends[MESH] |HIV Infections/drug therapy[MESH] |HIV/*drug effects[MESH] |Humans[MESH]The next ten stories on antiviral drug discovery (part E): advents, ad(epmc).pdf DeepDyve Pubget Overpricing